+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Post-Operative Cataract Surgery Inflammation - Pipeline Insight, 2025 - Product Thumbnail Image

Post-Operative Cataract Surgery Inflammation - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Rabies Immunoglobulins - Pipeline Insight, 2025 - Product Thumbnail Image

Rabies Immunoglobulins - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Radiation Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Radiation Dermatitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Urticaria- Pipeline Insight, 2025 - Product Thumbnail Image

Urticaria- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Mucopolysaccharidosis - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Ocular Graft Versus Host Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Ocular Graft Versus Host Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-33 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-33 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Rhinitis - Pipeline Insight, 2025 - Product Thumbnail Image

Rhinitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Graft Versus Host Disease (GvHD) - Pipeline Insight, 2025 - Product Thumbnail Image

Graft Versus Host Disease (GvHD) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Allergic Conjunctivitis - Pipeline Insight, 2025 - Product Thumbnail Image

Allergic Conjunctivitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Interleukin 8 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin 8 Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-12 Expression Stimulants - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-12 Expression Stimulants - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Interleukin 6 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin 6 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Immunoglobulin Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Immunoglobulin Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HIV Integrase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

HIV Integrase Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Lung Transplant Rejection - Pipeline Insight, 2025 - Product Thumbnail Image

Lung Transplant Rejection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Wiskott-Aldrich Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Wiskott-Aldrich Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Acute Graft-versus-Host Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Acute Graft-versus-Host Disease- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more